Microbiol Mol Biol Rev

2007, 71:36–47.PubMedCrossRef 21. Hynes MF, McGregor NF: Two plasmids other than the nodulation plasmid are necessary for formation PX-478 clinical trial of nitrogen-fixing nodules by Rhizobium leguminosarum . Mol Microbiol 1990, 4:567–574.PubMedCrossRef 22. Dehal PS, Joachimiak MP, Price MN, Bates JT, Baumohl JK, Chivian D, Friedland GD, Huang KH, Keller K, Novichkov PS, Dubchak IL, Alm EJ, Adam PA: MicrobesOnline: an integrated portal for comparative and functional genomics. Nucleic Acids Res 2010, 38:396–400.CrossRef 23. Williams KP, Sobral BW, Dickerman AW: A robust species tree for the Alphaproteobacteria . J Bacteriol 2007, 189:4578–4586.PubMedCrossRef 24. Guo X, Flores M, Mavingui P, Fuentes SI, Hernández G, Dávila G, Palacios R: Natural genomic design in Sinorhizobium meliloti : novel genomic architectures. Genome Res 2003,

13:1810–1817.PubMed 25. García-de los Santos A, Brom S: Characterization of two plasmid-borne lpsβ loci of Rhizobium etli required for lipopolysaccharide synthesis and for optimal interactions with plants. Mol Plant Microbe Interact 1997, 10:891–902.PubMedCrossRef 26. Noel KD, Sánchez A, Fernández L, selleck kinase inhibitor Leemans J, Cevallos MA: Rhizobium phaseoli symbiotic mutants with transposon Tn 5 insertions. J Bacteriol 1984, 158:148–155.PubMed 27. Encarnación VX809 S, Willms K, Mora J: Fermentative and aerobic metabolism in Rhizobium etli . J Bacteriol 1995, 177:3058–3066.PubMed 28. Sambrook J, Fitsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Press; 1989. 29. Schafer A, Tauch A, Jager W, Kalinowski J, Thierbach G, Puhler A: Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19:

selection of defined deletions in the chromosome of Corynebacterium glutamicum . Gene 1994, 145:69–73.PubMedCrossRef 30. García-de los Santos A, López E, Cubillas CA, Noel KD, Brom S, Romero D: Requirement of a plasmid-encoded catalase for survival of Rhizobium etli CFN42 in a polyphenol-rich environment. Appl Environ Microbiol 2008, 74:2398–2403.PubMedCrossRef 31. Flores M, González V, Brom S, Martinez E, Piñero D, Romero D, Dávila G, Palacios R: Reiterated DNA sequences in Rhizobium and Agrobacterium spp. J Bacteriol 1987, 169:5782–5788.PubMed 32. Altschul S, Madden T, Schaffer 5-Fluoracil mouse A, Zhang J, Zhang Z, Millar W, Lipman D: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389–3402.PubMedCrossRef 33. Poggio S, Abreu-Goodger C, Fabela S, Osorio A, Dreyfus G, Vinuesa P, Camarena L: A complete set of flagellar genes acquired by horizontal transfer coexists with the endogenous flagellar system in Rhodobacter sphaeroides . J Bacteriol 2007, 189:3208–3216.PubMedCrossRef 34. Edgar RC: MUSCLE: a multiple sequence alignment method with reduced time and space complexity.

However, the application researches of MnO2 as anode for lithium-ion battery were relatively few. MnO2 nanomaterials are recognized as anode materials since three-dimensional (3d) transition metal oxides (MO, where M is Fe, Co, Ni, www.selleckchem.com/products/gm6001.html and Cu) were proposed to serve as high theoretic capacity anodes for lithium-ion battery by Poizot et al. [18]. Before that, MnO2 nanomaterials were usually used to prepare LiMn2O4 crystals as cathode for lithium-ion battery [19, 20]. Chen’s research group has made great contributions on the research of anode for lithium-ion

battery [21, 22]. Nevertheless, compared to the intensive investigation on Fe2O3, Fe3O4, SnO2, CoO, and so on [23–28], the application investigation of MnO2 nanomaterials on anodes for lithium-ion battery is still immature, although the investigations on their preparation are plentiful. The research on MnO2 anode is relatively complex because MnO2 exists in

several crystallographic forms such as α-, β-, γ-, and δ-type. For example, Zhao et al. [22] reported γ-MnO2 crystals with hollow interior had high discharge capacity as 602.1 mAh g−1 after 20 cycles. Li et al. [15] found α-MnO2 with nanotube Ferrostatin-1 solubility dmso morphology exhibited high reversible capacity of 512 mAh g−1 at a high current density of 800 mA g−1 after 300 cycles. Thus, from the above two examples, we could summarize that the electrochemical performance of MnO2 crystals has relationship both with the crystallographic forms

and with the morphologies. Therefore, the researches on the relationship of electrochemical performance with the morphologies and the relationship of electrochemical performance with the crystallographic forms are very essential. In the present work, to enrich the relationship between electrochemical performances and morphologies, two α-MnO2 crystals with caddice-clew-like and urchin-like morphologies were prepared by hydrothermal method. For lithium-ion battery application, urchin-like α-MnO2 crystal with compact structure was found to have better electrochemical performance. Methods Synthesis and characterization of MnO2 micromaterials prepared by hydrothermal Lck method All reagents purchased from the Shanghai Chemical Company (Shanghai, China) were of analytical grade and used without further purification. The MnO2 micromaterials were prepared using the similar method described by Yu et al. [6] with some modifications. To prepare caddice-clew-like MnO2 micromaterial, 1.70 g MnSO4 · H2O was dissolved in 15-mL distilled water with vigorous stirring. When the solution was clear, 20-mL aqueous solution containing 2.72 g K2S2O8 was added to the above solution under continuous stirring. Then, the resulting transparent solution was transferred into a Epigenetics inhibitor Teflon-lined stainless steel autoclave (50 mL) of 80% capacity of the total volume. The autoclave was sealed and maintained at 110°C for 6 h.

strain Y2. J Bacteriol 2006,188(13):4812–4821.CrossRefPubMed 24. Kim HS, Kang TS, Hyun JS, Kang HS: Regulation of penicillin G acylase gene expression in Escherichia coli by repressor PaaX and

the cAMP-cAMP receptor protein complex. J Biol Chem 2004,279(32):33253–33262.CrossRefPubMed 25. Wasserman WW, Sandelin A: Applied bioinformatics for the NVP-HSP990 identification of regulatory elements. Nat Rev Genet 2004,5(4):276–287.CrossRefPubMed 26. Ross W, Gosink KK, Salomon J, Igarashi K, Zou C, Ishihama A, Severinov K, Gourse RL: A third recognition element in bacterial promoters: DNA binding by the alpha subunit of RNA polymerase. Science 1993,262(5138):1407–1413.CrossRefPubMed 27. Flannagan RS, Aubert D, Kooi C, Sokol PA, Valvano MA:Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo. Infect Immun 2007,75(4):1679–1689.CrossRefPubMed selleckchem 28. Saenger W, Orth P, Kisker C, Hillen W, Hinrichs W: The tetracycline repressor-A ARRY-438162 cell line paradigm for a biological switch. Angew Chem Int Ed Engl 2000,39(12):2042–2052.CrossRefPubMed 29. Ohtsubo Y, Goto H, Nagata Y, Kudo T, Tsuda M: Identification of a response regulator

gene for catabolite control from a PCB-degrading beta-proteobacteria, Acidovorax sp . KKS102. Mol Microbiol 2006,60(6):1563–1575.CrossRefPubMed 30. Yoder-Himes DR, Chain PS, Zhu Y, Wurtzel O, Rubin EM, Tiedje JM, Sorek R: Mapping the Burkholderia cenocepacia

niche response via high-throughput sequencing. Proc Natl Acad Sci USA 2009,106(10):3976–3981.CrossRefPubMed 31. Cormack BP, Valdivia RH, Falkow S: FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996,173(1 Spec No):33–38.CrossRefPubMed 32. Darling P, Chan M, Cox AD, Sokol PA: Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect Immun 1998,66(2):874–877.PubMed 33. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, Barrell B: Artemis: sequence visualization and annotation. Bioinformatics 2000,16(10):944–5.CrossRefPubMed 34. Hertz GZ, Stormo GD: Identifying DNA and protein patterns with statistically significant alignments of multiple sequences. Bioinformatics BCKDHB 1999,15(7–8):563–577.CrossRefPubMed 35. Schneider TD, Stephens RM: Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 1990,18(20):6097–6100.CrossRefPubMed 36. Sosinsky A, Bonin CP, Mann RS, Honig B: Target Explorer: An automated tool for the identification of new target genes for a specified set of transcription factors. Nucleic Acids Res 2003,31(13):3589–3592.CrossRefPubMed 37. Notredame C, Higgins DG, Heringa J: T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol 2000,302(1):205–217.CrossRefPubMed 38. Sambrook J, Russell DW: Molecular cloning: A laboratory manual 3 Edition Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y 2001. 39.

(XLS 26 KB) Additional file 4: Free-living expression of β-glucuronidase (GUS) under the control of the promoters of the following ORFs: A) clockwise from lower left—SMc01266;

greA (positive control for GUS expression); S. meliloti 1021 wild type (negative control #HDAC inhibitor randurls[1|1|,|CHEM1|]# for GUS expression); SMb20431; SMa1334. (The cropped plate wedges in panel A are all from the same plate.) B) clockwise from lower right—SMc01986; SMc01562; SMc03964; greA; S. meliloti 1021; a second streak of SMc03964. C) (clockwise from left) greA; S. meliloti 1021; SMb20360 (two separate strains). Specific strain names are shown in the photo labels. The growth medium is LBMC, with streptomycin 500 ug/mL. (JPEG 733 KB) Additional file 5 : Free-living expression of β-glucuronidase (GUS) under the control of the promoters of the following ORFs: A) SMa0044. Multiple isolates of the SMa0044::GUS fusions are shown in comparison with greA (positive control for GUS expression) and S. meliloti 1021 wild type (negative control for GUS expression). B) SMc00135. Multiple isolates of the SMc00135::GUS fusions are shown in comparison with greA and S. meliloti 1021 wild type. C) the SMc01424-01422 operon. Multiple isolates of the SMc01424-01422: GUS fusions

are shown in comparison with greA and S. meliloti 1021 wild type. The growth medium is LBMC, with streptomycin 500 ug/mL. GUS expression strains ACY-738 mouse that were tested for nodule expression are denoted with an asterisk and are described in Tables 3 and 4. (JPEG 1 MB) References 1. Jones KM, Kobayashi H, Davies BW, Taga ME, Walker GC: How rhizobial symbionts invade plants: the Sinorhizobium-Medicago model. Nat Rev Microbiol 2007,5(8):619–633.PubMedCrossRef 2. Gibson KE, Kobayashi H, Walker GC: Molecular determinants of a symbiotic chronic infection. Annu Rev Genet 2008, 42:413–441.PubMedCrossRef 3. Huang W: Data Sets: U.S. Fertilizer Use and Price. In. Edited by Service UER: usda.gov; 2008Huang W: Data Sets: U.S. Fertilizer Use and Price. In. Edited by Service UER: usda.gov;

2008 4. Peters NK, Frost JW, Long SR: A plant flavone, GPX6 luteolin, induces expression of Rhizobium meliloti nodulation genes. Science 1986, 233:977–980.PubMedCrossRef 5. Gage DJ: Infection and invasion of roots by symbiotic, nitrogen-fixing rhizobia during nodulation of temperate legumes. Microbiol Mol Biol Rev 2004,68(2):280–300.PubMedCrossRef 6. Oldroyd GE, Downie JA: Nuclear calcium changes at the core of symbiosis signalling. Curr Opin Plant Biol 2006,9(4):351–357.PubMedCrossRef 7. Timmers AC, Auriac MC, Truchet G: Refined analysis of early symbiotic steps of the Rhizobium-Medicago interaction in relationship with microtubular cytoskeleton rearrangements. Development 1999,126(16):3617–3628.PubMed 8. Catalano CM, Czymmek KJ, Gann JG, Sherrier DJ: Medicago truncatula syntaxin SYP132 defines the symbiosome membrane and infection droplet membrane in root nodules. Planta 2007,255(3):541–550.CrossRef 9.

Animal models and cell culture systems have provided indications that lactobacilli are able to counteract alterations in paracellular permeability evoked

by cytokines, chemicals, peptides, infections or stress [36]. A paper by Seth et al. [37] reported that the administration of live and heat inactivated L.GG, bacterial supernatants and peculiar L.GG purified soluble proteins to Caco-2 cells treated by hydrogen peroxide that destroys TER and increases permeability, caused the secretion of proteins of this strain effective against the insult. In our study, the administration of viable and heat killed L.GG as well as its conditioned medium, caused only a slight and not significant increase in TER after 90 min from exposure without any effects on lactulose flux and zonulin release. By opposite, in Caco-2 cells treated with gliadin, the addition of viable L.GG, but also L.GG-HK selleck compound and L.GG-CM, ATM Kinase Inhibitor cost significantly restored cell barrier function. Also the A-1210477 supplier single and total polyamine levels diminished significantly when Caco-2 cells were exposed to gliadin in combination with viable and heat killed L.GG. Recently, our group reported that the administration of viable, heat killed L.GG and L.GG homogenate to DLD-1 and HGC-27 cell lines significantly reduced neoplastic proliferation as well as polyamine content and biosynthesis [19, 20, 38]. As regards the protective effects

of some probiotics against gliadin, our findings are in line with data in literature [39] and

different mechanisms could be evoked to explain the effects exerted by L.GG, click here not only as viable bacteria, but also when they were heat inactivated or their conditioned medium was used. Firstly, L.GG might inhibit gliadin-induced damage in Caco-2 cells by hydrolyzing gliadin similarly to other live probiotic bacteria as in the VSL3# probiotic preparation [40]. These strains showed the ability to colonize the human stomach and duodenum, where the hydrolysis of gliadin epitopes may be relevant for decreasing the abnormal secretion of zonulin and the initial step of immune response to gliadin [41, 42]. Secondly, the peculiar set of peptidases shown by L.GG was probably able to inhibit the gliadin-induced damage to Caco-2 cells breaking up wheat gliadin into small harmless peptide products [43]. Thirdly, L.GG might modulate directly the function of epithelial cells. It has already been reported that different probiotic strains, probiotic bacterial lysates or conditioned medium increase epithelial barrier function as measured by TER [44]. In addition, L.GG might protect the epithelium from the gliadin insult by direct action on the cells. One interesting finding of the present study is that viable L.GG per se was able to significantly increase ZO-1, Claudin-1 and Occludin expression after 6 h of exposure. Even if the gliadin effects on TJ expression were significant only after 24 h, the co-administration of viable L.